275 related articles for article (PubMed ID: 1706379)
1. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.
Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC
J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379
[TBL] [Abstract][Full Text] [Related]
2. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
3. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
4. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
[TBL] [Abstract][Full Text] [Related]
5. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
[TBL] [Abstract][Full Text] [Related]
6. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
Wasik MA; Morimoto C
J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
[TBL] [Abstract][Full Text] [Related]
8. A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation.
Lorré K; Van Damme J; Ceuppens JL
Eur J Immunol; 1990 Jul; 20(7):1569-75. PubMed ID: 1974850
[TBL] [Abstract][Full Text] [Related]
9. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
10. CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.
Menu E; Tsai BC; Bothwell AL; Sims PJ; Bierer BE
J Immunol; 1994 Sep; 153(6):2444-56. PubMed ID: 7521361
[TBL] [Abstract][Full Text] [Related]
11. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
[TBL] [Abstract][Full Text] [Related]
12. CD2 regulates T cell-dependent induction of monocyte IL-1 beta mRNA during anti-CD3 mitogenesis.
McAllister PT; Ellis TM
Cell Immunol; 1996 May; 170(1):120-6. PubMed ID: 8660807
[TBL] [Abstract][Full Text] [Related]
13. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
14. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.
Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F
J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400
[TBL] [Abstract][Full Text] [Related]
15. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
16. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
17. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation.
Pierrès A; Lopez M; Cerdan C; Nunes J; Olive D; Mawas C
Eur J Immunol; 1988 May; 18(5):685-90. PubMed ID: 2454190
[TBL] [Abstract][Full Text] [Related]
18. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
19. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
20. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes.
Hivroz-Burgaud C; Clipstone NA; Cantrell DA
Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
